News & Events

Demeetra to Present Preclinical Data on Investigational Cannabinoid Derivatives at the 2025 Crohn’s and Colitis Congress Novel non-natural small molecules DM350-P and DM300 outperform natural cannabinoids, steroid and immune suppressant positive controls in a mouse Colitis and rat Crohn’s model. The data presented will highlight the significant impact of medicinal chemistry on cannabinoid pharmacology, demonstrating…55

Demeetra Cas-CLOVER Research Selected as a MDPI Journal Editor’s Choice Article Lexington, KY and Bloomington, IN: A pioneering study, authored by scientists from Demeetra and Indiana University, has been selected for the MDPI Journals Editor’s Choice Articles, highlighting the impact of advanced gene editing in synthetic biology to produce biopesticides. Published in Fermentation in 2023, Generation…55

Meet Demeetra at BioProcess International West Meet our team for an introduction to our CRISPR alternative, Cas-CLOVER™. You can also catch us at our poster “piggyBac Transposase and Cas-CLOVER Targeted Nuclease Enable Rapid Discovery of Novel Hot Spots in HEK293 Suspension Cells“ March 11-14, 2024Town and Country Resort, San Diego, California Conference Info Cas-CLOVER, The…55

Demeetra is attending PepTalk! PepTalk provides a comprehensive program and innovative solutions in antibody development, biologics characterization, and expression platforms. January 16-19, 2024 Hilton San Diego Bayfront – San Diego, CA Conference Info Meet with Demeetra! Gianguido Coffa will be attending PepTalk on January 16-17. While attending, he would love to meet in person to…55

We’re attending the Plant & Animal Genome Conference PAG31 is the premier and largest Ag genomics meeting in the world. Meet us there to learn how our gene editing tools, Cas-CLOVER nuclease and piggyBac transposase, can enable research and commercial product development. Conference Info Meet with Demeetra! Gianguido Coffa will be attending PAG31. While attending,…55

Dublin, Ireland and Kentucky, USA, September 12: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Demeetra AgBio (‘Demeetra’). This is a non-exclusive licensing agreement granting Demeetra access to the ERS CRISPR/Cas9 patent portfolio which is sublicensable when combined with Cas-CLOVER.55

The Industrializing Cultivated Meats & Seafood Summit is your one-stop-shop for optimizing products through precise and clean gene editing and progressing your products to shelves and tabletops across the globe.

Sanofi’s Tiffany McLamarrah presented “Capitalizing on the Power of Next Generation Gene Editing Using Cas-CLOVER” at 10:00 am on Conference Day 2. This presentation underscores the growing recognition of Cas-CLOVER’s transformative potential in advanced gene editing applications. Sanofi’s adoption and thorough evaluation of Cas-CLOVER provide critical external validation for the platform, particularly in the cell…

The BIO International Convention is the world’s largest biotechnology event, bringing together leaders and innovators from across the biotech industry to network, collaborate, and learn about the latest advances in biotechnology.